The effects of low GSH can lead to a laundry list of unwanted medical conditions and disease states
Interestingly, these effects were more pronounced in the high-dose APLA group compared to PLA, suggesting dose- and type-dependent neurotoxicity (Qian et al., 2025)
A common and convenient site is the subcutaneous fat of the abdomen, as the peptide will be absorbed into the bloodstream and distributed throughout the body
Cao G, Gong T, Du Y, Wang Y, Ge T, Liu J
An imbalance in glutathione metabolism, defined by lower GSH:GSSG, has been linked to a number of chronic diseases including feline chronic renal failure (Reference Keegan and Webb43) and in humans, cancer, neurodegenerative disorders, cystic fibrosis, viral infection, diabetes mellitus, renal failure and liver disease (Reference Wu, Fang and Yang44)
No direct human trial has evaluated this combination